Impax gets FDA approval for antibiotic
HAYWARD, Calif. (AP) — Impax Laboratories Inc. said Friday it received Food and Drug Administration approval for a generic version of 150-milligram capsules of the antibiotic Adoxa, which is used to treat bacterial infections.
Impax said the 150-milligram capsule version had sales of $25 million in the U.S. in 2010.
There are several generic versions of Adoxa already on the market.
Shares of Impax rose 48 cents, or 2.1 percent, to $23.73 in morning trading. The stock has traded between $7.20 and $24.79 over the last 52 weeks.
Feb 24, 2011